Old Web
English
Sign In
Acemap
>
authorDetail
>
Viera Skarbova
Viera Skarbova
Adverse effect
Cmax
Pharmacokinetics
Medicine
Tolerability
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The pharmacokinetics of pamiparib in the presence of a strong CYP3A inhibitor (itraconazole) and strong CYP3A inducer (rifampin) in patients with solid tumors: an open-label, parallel-group phase 1 study.
2021
Cancer Chemotherapy and Pharmacology
Song Mu
Chester Lin
Anna Skrzypczyk-Ostaszewicz
Iurie Bulat
Marina Maglakelidze
Viera Skarbova
Claudia Andreu-Vieyra
Srikumar Sahasranaman
Show All
Source
Cite
Save
Citations (1)
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment.
2021
Cancer Chemotherapy and Pharmacology
Nikolay Grechko
Viera Skarbova
Monika Tomaszewska-Kiecana
Rodryg Ramlau
Piotr Centkowski
Yvette Drew
Rafal Dziadziuszko
Milada Zemanová
Jeri Beltman
Eileen Nash
Jenn Habeck
Mingxiang Liao
Jim J. Xiao
Show All
Source
Cite
Save
Citations (0)
1